The takeover drama of Britain's AstraZeneca by US drugs giant Pfizer has now reached British prime minister David Cameron's doorstep. In...
Read morePfizer Inc. has announced the election of James C. Smith to its Board of Directors, effective immediately. Mr. Smith also...
Read morePar Pharmaceutical Companies, Inc. today issued the following statement in response to inquiries it has received regarding the potential use...
Read moreThe US crackdown on healthcare fraud is paying huge dividends to the exchequer, accounting for three quarters of the money...
Read moreProveblue(R) is the methylthioninium chloride or Methylene Blue active substance patented by Provepharm, compliant with current European Pharmacopeia standards Provepharm,...
Read moreLarge amounts of information generated by gene expression profiling will increase implementation of data management toolsGene expression profiling can bring...
Read moreUS-based Immune Design has started dosing patients in a Phase I clinical study of LV305, an immuno-oncology investigational agent from...
Read moreOn Friday, June 06, 2014, the NASDAQ Composite ended at 4,321.40, up 0.59%, the Dow Jones Industrial Average finished the...
Read moreUS-based biotechnology firm Edge Therapeutics has started enrolling patients in the second group of a multicenter, randomised, controlled, open-label, Phase...
Read moreUS-based Arena Pharmaceuticals has started dosing patients in an investigational Phase Ib clinical trial of APD334, an oral drug candidate...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
